Combined Breast Cancer Risk Study

Completed

Conditions studied: Hereditary Cancer

In brief

A prospective, non-interventional study in women 18 to 84 years of age. Subjects will provide a sample for genetic testing and information about their medical and family history. The results of the genetic test will be combined with clinical data to validate a method of predicting breast cancer risk.

Key facts

Study ID

NCT03067389

Run by

Myriad Genetic Laboratories, Inc.

People needed

553

Starts

2016-02-06

Expected to finish

2019-01-08

Last updated by the study team

2019-01-15

Who can join

Age: 18 and older, up to 84. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women without breast cancer:
• 18 to 84 years of age
• Western/Northern European, Central/Eastern European, or Ashkenazi ancestry
• No history of invasive breast cancer
• Women with a history of breast cancer:
• 18 to 84 years of age
• Western/Northern European, Central/Eastern European, or Ashkenazi ancestry
• Pathologically confirmed invasive breast cancer diagnosed within the past 12 months

You may not qualify if…

• Unwilling to provide written informed consent
• Women with history of ductal carcinoma in situ (DCIS).
• Patient has had a prior breast biopsy, exclusive of a breast biopsy diagnostic of breast cancer, that showed either hyperplasia, atypical hyperplasia, lobular carcinoma in situ (LCIS), or the specific histologic result is unknown to the patient

Where it is running

• The Breast Center of Northwest Arkansas — Fayetteville, Arkansas, United States
• Bethesda Health — Boynton Beach, Florida, United States
• Cuda Women's Health Center — Hyannis, Massachusetts, United States
• Elizabeth Wende Breast Care — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.